<DOC>
	<DOC>NCT00741611</DOC>
	<brief_summary>This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.</brief_summary>
	<brief_title>Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Patients with symptomatic paroxysmal atrial fibrillation who have failed at least one class I or III antiarrhythmic drug Other inclusion criteria Previous surgical or catheter ablation to treat AF Permanent AF Uncontrolled or unstable medical conditions Other exclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>